🇺🇸 PFE — Pfizer Inc.

Healthcare Compra
← Volver

Precio actual

27,79 USD

Máx. histórico

61,71

1723 días

Split 1054:1000 del 17/11/2020

Caída desde máximo

-54,97%

Rango 52 semanas

23,58 – 29,21

Variación hoy

-2,32%

Cierre anterior

28,45

Rango de hoy

27,72 – 28,15

Volumen hoy

31.727.745

Información
Nombre completo
Pfizer Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
75.000
PER
36,57 (puede no estar actualizado)
Dividend yield
6,05% (puede no estar actualizado)
Precio objetivo analistas
28,61 USD (puede no estar actualizado)
Primera cotización
01/06/1972
Precio actualizado
hace 8 horas
Sobre la empresa

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Dividendos repartidos Total últimos 12 meses: 1,7200 USD · Yield: 6,19%
Fecha de pago Importe por participación
07/11/2007 0,2751 USD
08/08/2007 0,2751 USD
09/05/2007 0,2751 USD
07/02/2007 0,2751 USD
08/11/2006 0,2277 USD
09/08/2006 0,2277 USD
10/05/2006 0,2277 USD
08/02/2006 0,2277 USD
08/11/2005 0,1803 USD
10/08/2005 0,1803 USD
11/05/2005 0,1803 USD
09/02/2005 0,1803 USD
09/11/2004 0,1613 USD
11/08/2004 0,1613 USD
12/05/2004 0,1613 USD
Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2020 1054:1000
01/07/1999 3:1
01/07/1997 2:1
03/07/1995 2:1
01/04/1991 2:1
01/07/1983 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
01/04/1999 44,10 44,30 43,64 44,14 +0,59% 1,48% 5.923.058
31/03/1999 45,24 45,36 43,84 43,88 -2,42% 3,36% 7.267.541
30/03/1999 44,28 45,15 44,10 44,97 +0,84% 2,37% 6.247.480
29/03/1999 43,01 44,59 42,97 44,59 +4,44% 3,77% 7.117.346
26/03/1999 43,47 43,56 42,66 42,69 -2,00% 2,09% 7.616.626
25/03/1999 43,47 43,86 43,17 43,56 -0,27% 1,59% 8.174.719
24/03/1999 43,98 44,22 42,93 43,68 -0,81% 2,92% 9.444.894
23/03/1999 45,44 45,70 43,82 44,04 -2,66% 4,13% 8.959.211
22/03/1999 44,43 45,52 44,30 45,24 +1,64% 2,76% 5.701.086
19/03/1999 45,22 45,26 44,34 44,51 -1,57% 2,05% 7.880.653
18/03/1999 44,35 45,40 43,74 45,22 +1,96% 3,74% 7.086.042
17/03/1999 44,91 44,91 44,04 44,35 -1,23% 1,94% 6.184.240
16/03/1999 44,69 45,15 44,24 44,91 +0,84% 2,03% 6.954.819
15/03/1999 44,35 44,79 44,10 44,53 +0,31% 1,56% 7.567.615
12/03/1999 44,35 44,43 43,80 44,39 -0,18% 1,43% 7.130.942
11/03/1999 44,53 44,57 44,00 44,47 +0,72% 1,29% 9.011.700
10/03/1999 44,18 44,28 43,94 44,16 +0,72% 0,76% 6.734.744
09/03/1999 44,18 44,79 43,84 43,84 -0,67% 2,15% 9.956.822
08/03/1999 43,15 44,24 42,87 44,14 +2,20% 3,16% 10.374.838
05/03/1999 42,46 43,19 42,32 43,19 +2,77% 2,05% 8.821.980
04/03/1999 41,67 42,28 41,39 42,02 +1,00% 2,13% 9.090.118
03/03/1999 42,08 42,32 41,39 41,61 -1,08% 2,21% 6.703.756
02/03/1999 42,22 42,66 42,04 42,06 -0,09% 1,45% 7.307.066
01/03/1999 41,45 42,22 41,11 42,10 +0,90% 2,67% 5.484.805
26/02/1999 41,43 41,90 40,94 41,73 +0,81% 2,34% 7.183.432
25/02/1999 41,71 41,94 40,86 41,39 -1,23% 2,61% 7.953.695
24/02/1999 42,40 42,66 41,81 41,90 -1,03% 2,00% 6.897.903
23/02/1999 42,02 42,66 41,71 42,34 +0,66% 2,26% 8.065.630
22/02/1999 40,58 42,32 40,56 42,06 +3,65% 4,33% 8.535.503
19/02/1999 40,76 41,09 40,42 40,58 -2,14% 1,65% 8.846.960